Consolidated Statement Of Income

K Pharma,Inc. - Filing #7344418

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Consolidated statement of income
Statement of income
Net sales
1,000,000,000 JPY
JPY
Operating expenses
Selling, general and administrative expenses
543,942,000 JPY
353,772,000 JPY
Taxes and dues
29,071,000 JPY
20,419,000 JPY
Cost of sales
90,000,000 JPY
JPY
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
69,200,000 JPY
50,386,000 JPY
Operating expenses
Operating profit (loss)
366,057,000 JPY
-353,772,000 JPY
Operating expenses
Research and development expenses
255,417,000 JPY
163,971,000 JPY
General and administrative expenses
Salaries
Ordinary profit (loss)
344,184,000 JPY
-359,233,000 JPY
Gross profit (loss)
910,000,000 JPY
JPY
Net sales
Non-operating income
Interest income
16,000 JPY
7,000 JPY
Non-operating income
66,000 JPY
52,000 JPY
Cost of sales
Selling, general and administrative expenses
Non-operating expenses
Other
90,000 JPY
90,000 JPY
Non-operating expenses
21,939,000 JPY
5,514,000 JPY
Share issuance costs
11,849,000 JPY
5,424,000 JPY
Extraordinary losses
43,107,000 JPY
31,293,000 JPY
Impairment losses
43,107,000 JPY
31,293,000 JPY
Gross profit
Profit (loss) before income taxes
301,076,000 JPY
-390,526,000 JPY
Income taxes - current
40,746,000 JPY
1,900,000 JPY
Extraordinary losses
Income taxes
40,746,000 JPY
1,900,000 JPY
Profit (loss)
260,330,000 JPY
260,330,000 JPY
260,330,000 JPY
260,330,000 JPY
-392,427,000 JPY
-392,427,000 JPY
-392,427,000 JPY
-392,427,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.